0001179110-20-003316.txt : 20200309 0001179110-20-003316.hdr.sgml : 20200309 20200309171718 ACCESSION NUMBER: 0001179110-20-003316 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200305 FILED AS OF DATE: 20200309 DATE AS OF CHANGE: 20200309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KWON YOUNG CENTRAL INDEX KEY: 0001733094 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 20698874 MAIL ADDRESS: STREET 1: C/O MOMENTA PHARMACEUTICALS INC. STREET 2: 675 WEST KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2020-03-05 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001733094 KWON YOUNG C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Financial & Bus. Officer Common Stock 2020-03-05 4 A 0 15000 0 A 146192 D Common Stock 2020-03-06 4 S 0 7356 28.96 D 138836 D Restricted Stock Units 2020-03-05 4 A 0 15000 0 A Common Stock 15000 15000 D Shares received pursuant to settlement of Performance Stock Units that were granted on October 17, 2018. Includes 1,089 shares acquired under the issuer's employee stock purchase plan at a price of $9.76 per share on January 31, 2020. This transaction was effected pursuant to a Rule 10b5-1 trading plan Each Restricted Stock Unit represents a contingent right to receive one share of MNTA Common Stock. Subject to the officer's continued employment with the company, the Restricted Stock Units will vest on March 5, 2021. /s/ R.Mark Chamberlin as attorney in fact 2020-03-09